FCGBP and neoplasm: At the univariate level, elevated FCGBP immunoexpression (Figure 3A–3C), low tumor regression grade, advanced post-CRT tumoral status, positive post-CRT lymph node status, and the presence of vascular invasion were significantly and adversely associated with all three endpoints (all p ≤ 0.0434).